Interestingly, some of the biomarkers which associated with the extent of TB disease that changed consistently with treatment in the present study, are typically thought of as markers of B-cell mediated immunity: BLR1, CD19 and FCGR1A. (Supplementary Table 1). The gene discussed is FCGR1A; the disease is tuberculosis.